PCVX FY 2024 Earnings — Vaxcyte, Inc. Revenue & Financial Results | Market Cap Arena

PCVXVaxcyte, Inc.

$9B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$570M

Net Income

-$464M

EPS (Diluted)

$-3.80

Cash Flow

Operating Cash Flow

-$453M

Free Cash Flow

-$475M

Stock-Based Comp.

$85M

Balance Sheet

Total Assets

$3.5B

Total Liabilities

$205M

Stockholders' Equity

$3.3B

Cash & Equivalents

$388M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$570M	-$468M	-21.7%
Net Income	-$464M	-$402M	-15.3%